secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001493152-24-041589
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences reduces stockholder quorum to 1/3 of votes, effective Nov 1, 2024
--------------------------------------------------------------------------------

- Bylaw amendment lowers quorum from majority to 1/3 of total votes entitled to be cast.
- Change approved by board on October 17, 2024; effective November 1, 2024.
- No other amendments or fiscal year changes were reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224041589/0001493152-24-041589-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224041589/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041589

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer